Panjon

Panjon02 May 2024

Pharmaceuticals

₹

+0.10 (+0.50%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Panjon

Panjon

Pharmaceuticals

Panjon02 May 2024

₹

+0.10 (+0.50%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
16-Mar-2024	BC	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/03/2024 inter alia to consider and approve 1. Conversion of 810826 Convertible Warrants into E	21-Mar-2024
22-Mar-2024	BC	Jay Kothari	21-Mar-2024
05-Feb-2024	BC	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Board Meeting is scheduled to be held on 13 Februar	13-Feb-2024
30-Jan-2024	BC	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve Board Meeting is scheduled to be held on Friday02/0	02-Feb-2024
30-Oct-2023	BC	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve In pursuant to Regulation 29(1) and 33 of Securitie	08-Nov-2023

No Rights has been declared by Panjon

Book Closure

Record Date	Split Date	Purpose
21-Mar-2024	-	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/03/2024 inter alia to consider and approve 1. Conversion of 810826 Convertible Warrants into E
21-Mar-2024	-	Jay Kothari
13-Feb-2024	-	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Board Meeting is scheduled to be held on 13 Februar
02-Feb-2024	-	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve Board Meeting is scheduled to be held on Friday02/0
08-Nov-2023	-	PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve In pursuant to Regulation 29(1) and 33 of Securitie

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Panjon Ltd ₹20.20(+0.10/0.50%)	20.20	+0.10	31.15	37.77	335.00	2.30
Astrazeneca Pharma India Ltd ₹5,211.30(-129.95/-2.43%)	5,211.30	-129.95	13,353.13	68.03	83.72	20.39
Bliss GVS Pharma Ltd ₹125.70(+2.00/1.62%)	125.70	+2.00	1,295.03	60.30	18.97	1.32
Cipla Ltd ₹1,412.95(+11.75/0.84%)	1,412.95	+11.75	113,132.18	52.94	34.40	4.37
Abbott India Ltd ₹26,333.05(-82.70/-0.31%)	26,333.05	-82.70	56,133.47	18.05	49.00	18.06
Amrutanjan Health Care Ltd ₹709.10(+11.15/1.60%)	709.10	+11.15	2,017.82	15.18	45.86	7.70

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	4.81	1.30	1.24	1.30	1.37	1.93
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4.81	1.30	1.24	1.30	1.37	1.93
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.06	0.04	0.08	0.24	0.04	0.05
Total Income	4.87	1.34	1.32	1.54	1.42	1.98
Total Expenditure	4.81	1.27	1.28	1.41	1.35	1.88
PBIDT	0.07	0.07	0.04	0.13	0.07	0.09
Interest	0.01	0.01	0.00	0.02	0.01	0.01
PBDT	0.06	0.06	0.04	0.11	0.06	0.09
Depreciation	0.02	0.02	0.02	0.11	0.03	0.03
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.04	0.04	0.02	0.00	0.03	0.05
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.04	0.04	0.02	0.00	0.03	0.05

EPS (Unit Curr.)	0.02	0.02	0.00	0.00	0.02	0.00
EPS (Adj) (Unit Curr.)	0.02	0.02	0.00	0.00	0.02	0.00
Calculated EPS (Unit Curr.)	0.03	0.03	0.01	0.00	0.02	0.03
Calculated EPS (Adj) (Unit Curr.)	0.03	0.03	0.01	0.00	0.02	0.03
Calculated EPS (Ann.) (Unit Curr.)	0.11	0.10	0.06	-0.01	0.07	0.14
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.11	0.10	0.06	-0.01	0.07	0.14
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	15.50	15.50	15.50	15.50	15.50	15.50
Reserve & Surplus	1.00	1.00	1.00	1.00	1.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	1.46	5.38	3.23	10.00	5.11	4.66
PBDTM(%)	1.25	4.62	3.23	8.46	4.38	4.66
PATM(%)	0.83	3.08	1.61	0.00	2.19	2.59

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	15.50	15.50	15.50	15.50	15.50	15.50
Reserves Total	-2.02	-2.84	1.31	1.23	1.27	1.13
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	13.48	12.66	16.81	16.73	16.77	16.63
Secured Loans	0.28	0.81	0.86	0.89	0.04	0.07
Unsecured Loans	0.50	0.00	0.47	0.67	1.80	1.82
Total Debt	0.78	0.81	1.33	1.56	1.84	1.89
Total Liabilities	14.26	13.47	18.14	18.29	18.61	18.52
APPLICATION OF FUNDS :
Gross Block	8.02	7.84	7.66	7.59	7.07	6.58
Less : Accumulated Depreciation	7.11	6.90	6.69	6.47	6.20	5.86
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.91	0.94	0.97	1.12	0.87	0.72
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.08	1.07	1.07	1.08	1.09	1.09
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.48	3.77	3.87	3.81	3.62	3.35
Sundry Debtors	1.56	0.61	3.71	3.30	1.68	0.93
Cash and Bank	1.47	1.44	0.31	0.28	0.50	0.37
Loans and Advances	4.14	3.11	4.16	4.10	3.62	3.32
Total Current Assets	10.64	8.92	12.05	11.49	9.43	7.97
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.36	0.24	0.91	0.74	0.25	0.11
Provisions	0.28	0.34	0.21	0.19	0.10	0.19
Total Current Liabilities	0.64	0.58	1.12	0.93	0.35	0.30
Net Current Assets	10.01	8.35	10.94	10.56	9.08	7.68
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.19	0.60	0.67	0.85	0.85	0.94
Deferred Tax Liability	0.00	0.12	0.07	0.18	0.00	0.00
Net Deferred Tax	1.19	0.48	0.60	0.67	0.85	0.94
Total Assets	13.19	10.85	13.57	13.43	11.89	10.43
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.44	0.31	0.28	0.50	0.37
Net Cash from Operating Activities	0.04	1.82	0.34	0.35	0.49
Net Cash Used In Investing Activities	-0.19	-0.19	-0.06	-0.51	-0.31
Net Cash Used In Financing Activities	0.18	-0.51	-0.24	-0.07	-0.05
Net Inc./Dec In Cash And Cash Equivalents	0.04	1.12	0.04	-0.22	0.13
Cash And Cash Equivalents At End Of The Year	1.47	1.44	0.31	0.28	0.50

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

52.03%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

47.97%

**Promoter pledged shareholding 52.03%

About Panjon Ltd

Panjon Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 31.15 crores. It has reported a sales of Rs. 4.81 crores and a net profit of Rs. 0.04 crores for the quarter ended December 2018. The company management includes Jay Kothari, Jay Kothari,Prakash Doshi,Amit Mangalchand Mehta,Anjali Shukla,Anju Kothari,Pooja Bhandari (Panjon Ltd) among others.

Chairman

Jay Kothari

Registered office

01 Panjon Farm House,Airport Bijasan Road,Indore,Madhya Pradesh,452005

FAX :

Background

Incorporation Year1983

Face Value₹10

Market Lot1

How to buy Panjon shares on nse?

To buy Panjon shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Panjon share price today?

The Panjon shares price on nse is Rs.20.2 today.

What is the market cap of Panjon shares on BSE ?

The company has a market capitalization of Rs.31.15Cr

What is the PE & PB ratio of Panjon shares ?

PE is 335 and PB is 2.3

What is the 52 Week High and Low of Panjon shares?

Panjon stock price high: Rs.21.79 Panjon stock price low: Rs.11.9